Preclinical development of an immunomodulatory agent capable of mitigating influenza related hypercytokinemia
Ended Project Grant Awarded Last action
- Award ID
- R44AI152726
- Recipient
-
Cytoagents Inc. UEI CCEZCKNKL9M4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,288,849
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $2,475,335.03 Federal
- $813,514.00 Non-federal
- Place of performance
- Allegheny-West, PA 15212, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$1 | $0 | |
| Amendment | $813,514 | $0 | |
| Amendment | $813,514 | $813,514 | |
| Amendment | $0 | $0 | |
| Original award | $848,308 | $0 |
Quick answers
Who received award R44AI152726?
R44AI152726 was awarded to Cytoagents Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 8, 2020.
How much is award R44AI152726 worth?
$3,288,849 has been obligated on R44AI152726: $2,475,335 in federal funding and $813,514 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award